Wakefield Health in trading halt

Trading in shares of Wakefield Health on the New Zealand stock exchange has been halted this morning, "pending a material announcement".

The company reported pressure on earnings in its report, for the half year to September 30, but is lightly geared at 8.8% debt to equity, and said in the half-year report that Wakefield "continues to explore opportunities for growth through merger or acquisition".

It is also in the midst of major capital works to redevelop Wellington's Bowen Hospital.

Wakefield shares last traded at $7.04, having fallen 21.78% in the last six months, but risen slightly (2.9%) in the last week.

Businesswire.co.nz

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Printable version

Related News

Wakefield discovers past banking covenant breach, now remedied
Wakefield 1st half net profit up nearly 33%
Wakefield reports buoyant start to the year but expects weaker second half
Wakefield warns of further quake-strengthening costs
Wakefield Health to tap investors for $15 mln to pay for acquisitions
Wakefield spends $6.8 mln on specialist Auckland clinics
Wakefield Health mails out bid for Norfolk
Daily ShareChat: Wakefield Health
Wakefield bid for Norfolk stumbles again
Wakefield sweetens offer for Norfolk

Get quotes for Wakefield Health Limited Ordinary Shares (WFD)